Kenji Mizumoto

InstitutionKyoto University
AddressKyoto
Japan
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 15 Covid-19 publications, with a maximum of 2 publications in April 2020 and May 2020 and June 2020 and July 2020 and May 2021
    All Publications
    Bar chart showing 132 publications over 25 distinct years, with a maximum of 14 publications in 2001
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Chowell G, Dahal S, Bono R, Mizumoto K. Harnessing testing strategies and public health measures to avert COVID-19 outbreaks during ocean cruises. Sci Rep. 2021 07 29; 11(1):15482. PMID: 34326439.
      Citations:    Fields:    Translation:HumansPHPublic Health
    2. Akhmetzhanov AR, Mizumoto K, Jung SM, Linton NM, Omori R, Nishiura H. Estimation of the Actual Incidence of Coronavirus Disease (COVID-19) in Emergent Hotspots: The Example of Hokkaido, Japan during February-March 2020. J Clin Med. 2021 May 28; 10(11). PMID: 34071502.
      Citations: 2     
    3. Dahal S, Banda JM, Bento AI, Mizumoto K, Chowell G. Characterizing all-cause excess mortality patterns during COVID-19 pandemic in Mexico. BMC Infect Dis. 2021 May 07; 21(1):432. PMID: 33962563.
      Citations: 6     Fields:    Translation:Humans
    4. Undurraga EA, Chowell G, Mizumoto K. COVID-19 case fatality risk by age and gender in a high testing setting in Latin America: Chile, March-August 2020. Infect Dis Poverty. 2021 Feb 03; 10(1):11. PMID: 33531085.
      Citations: 20     Fields:    Translation:Humans
    5. Mizumoto K, Dahal S, Chowell G. Spatial variability in the risk of death from COVID-19 in Italy. Int J Tuberc Lung Dis. 2020 08 01; 24(8):829-837. PMID: 32912388.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    6. Munayco C, Chowell G, Tariq A, Undurraga EA, Mizumoto K. Risk of death by age and gender from CoVID-19 in Peru, March-May, 2020. Aging (Albany NY). 2020 07 21; 12(14):13869-13881. PMID: 32692724.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    7. Mizumoto K, Kagaya K, Chowell G. Early epidemiological assessment of the transmission potential and virulence of coronavirus disease 2019 (COVID-19) in Wuhan City, China, January-February, 2020. BMC Med. 2020 07 15; 18(1):217. PMID: 32664866.
      Citations: 29     Fields:    Translation:HumansCellsPHPublic Health
    8. Mizumoto K, Chowell G. Estimating Risk for Death from Coronavirus Disease, China, January-February 2020. Emerg Infect Dis. 2020 06; 26(6):1251-1256. PMID: 32168464.
      Citations: 70     Fields:    Translation:HumansCellsPHPublic Health
    9. Mizumoto K, Kagaya K, Chowell G. Effect of a wet market on coronavirus disease (COVID-19) transmission dynamics in China, 2019-2020. Int J Infect Dis. 2020 Aug; 97:96-101. PMID: 32497812.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    10. Shim E, Mizumoto K, Choi W, Chowell G. Estimating the Risk of COVID-19 Death During the Course of the Outbreak in Korea, February-May 2020. J Clin Med. 2020 May 29; 9(6). PMID: 32485871.
      Citations: 14     
    11. Omori R, Mizumoto K, Nishiura H. Ascertainment rate of novel coronavirus disease (COVID-19) in Japan. Int J Infect Dis. 2020 Jul; 96:673-675. PMID: 32389846.
      Citations: 20     Fields:    Translation:HumansCellsPHPublic Health
    12. Omori R, Mizumoto K, Chowell G. Changes in testing rates could mask the novel coronavirus disease (COVID-19) growth rate. Int J Infect Dis. 2020 May; 94:116-118. PMID: 32320809.
      Citations: 39     Fields:    Translation:HumansCellsPHPublic Health
    13. Chowell G, Mizumoto K. The COVID-19 pandemic in the USA: what might we expect? Lancet. 2020 04 04; 395(10230):1093-1094. PMID: 32247381.
      Citations: 39     Fields:    Translation:HumansCellsPHPublic Health
    14. Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. 2020 03; 25(10). PMID: 32183930.
      Citations: 851     Fields:    Translation:HumansCellsPHPublic Health
    15. Mizumoto K, Chowell G. Transmission potential of the novel coronavirus (COVID-19) onboard the diamond Princess Cruises Ship, 2020. Infect Dis Model. 2020; 5:264-270. PMID: 32190785.
      Citations: 95     
    16. Nishiura H, Endo A, Saitoh M, Kinoshita R, Ueno R, Nakaoka S, Miyamatsu Y, Dong Y, Chowell G, Mizumoto K. Identifying determinants of heterogeneous transmission dynamics of the Middle East respiratory syndrome (MERS) outbreak in the Republic of Korea, 2015: a retrospective epidemiological analysis. BMJ Open. 2016 Feb 23; 6(2):e009936. PMID: 26908522.
      Citations: 19     Fields:    Translation:HumansPHPublic Health
    17. Nishiura H, Miyamatsu Y, Mizumoto K. Objective Determination of End of MERS Outbreak, South Korea, 2015. Emerg Infect Dis. 2016 Jan; 22(1):146-8. PMID: 26689765.
      Citations: 16     Fields:    Translation:HumansCellsPHPublic Health
    18. Mizumoto K, Endo A, Chowell G, Miyamatsu Y, Saitoh M, Nishiura H. Real-time characterization of risks of death associated with the Middle East respiratory syndrome (MERS) in the Republic of Korea, 2015. BMC Med. 2015 Sep 30; 13:228. PMID: 26420593.
      Citations: 17     Fields:    Translation:HumansPHPublic Health
    19. Mizumoto K, Saitoh M, Chowell G, Miyamatsu Y, Nishiura H. Estimating the risk of Middle East respiratory syndrome (MERS) death during the course of the outbreak in the Republic of Korea, 2015. Int J Infect Dis. 2015 Oct; 39:7-9. PMID: 26275845.
      Citations: 23     Fields:    Translation:HumansPHPublic Health
    20. Nishiura H, Ejima K, Mizumoto K. Missing information in animal surveillance of MERS-CoV. Lancet Infect Dis. 2014 Feb; 14(2):100. PMID: 24457168.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    21. Nishiura H, Mizumoto K, Ejima K, Zhong Y, Cowling B, Omori R. Incubation period as part of the case definition of severe respiratory illness caused by a novel coronavirus. Euro Surveill. 2012 Oct 18; 17(42). PMID: 23098822.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    Mizumoto's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (131)
    Explore
    _
    Co-Authors (25)
    Explore
    _
    Similar People (60)
    Explore
    _